Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Neoplastic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT01437514
What this trial is testing

Effective Study of Preoperative Short-course Radiotherapy for the Advanced Resectable Rectal Cancer

Who this might be right for
Rectal Neoplasms
West China Hospital 410
Early research (Phase 1)UnknownNCT06329206
What this trial is testing

A Phase Ia/Ib Study of GH2616 Tablet in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Suzhou Genhouse Bio Co., Ltd. 156
Testing effectiveness (Phase 2)Study completedNCT03322384
What this trial is testing

UCDCC#271: Phase I/II Trial of Epacadostat, Intralesional SD101, Radiotherapy in Patients With Lymphoma

Who this might be right for
Advanced Solid TumorsLymphoma
University of California, Davis 20
Early research (Phase 1)UnknownNCT05798533
What this trial is testing

Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)

Who this might be right for
Solid Tumor
BGI, China 6
Early research (Phase 1)Not Yet RecruitingNCT06528249
What this trial is testing

Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced Malignancies

Who this might be right for
CancerSolid TumorHematologic Malignancy
Zhejiang Provincial People's Hospital 39
Testing effectiveness (Phase 2)Study completedNCT04539938
What this trial is testing

Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer

Who this might be right for
HER2 Positive Breast Cancer
Seagen, a wholly owned subsidiary of Pfizer 70
Testing effectiveness (Phase 2)UnknownNCT04755738
What this trial is testing

Almonertinib Plus Microwave Ablation in Advanced Non-small Cell Lung Cancer

Who this might be right for
Advanced Non Small Cell Lung Cancer
Qianfoshan Hospital 234
Large-scale testing (Phase 3)Active Not RecruitingNCT03975647
What this trial is testing

Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Seagen, a wholly owned subsidiary of Pfizer 466
Not applicableStudy completedNCT00502463
What this trial is testing

Induction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical Trial

Who this might be right for
Head and Neck Cancer
Austrian South Oncology Group 51
Testing effectiveness (Phase 2)Study completedNCT00244998
What this trial is testing

Fulvestrant in Treating Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute 20
Early research (Phase 1)Looking for participantsNCT04169763
What this trial is testing

Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

Who this might be right for
Stage II Vulvar Cancer AJCC v8Stage III Vulvar Cancer AJCC v8Stage IIIA Vulvar Cancer AJCC v8+3 more
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT01444521
What this trial is testing

Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Chinese Academy of Medical Sciences 50
Testing effectiveness (Phase 2)WithdrawnNCT03991104
What this trial is testing

SOX-based CRT for Esophageal Cancer.

Who this might be right for
Esophageal Cancer
Zhejiang Provincial People's Hospital
Testing effectiveness (Phase 2)Study completedNCT00045747
What this trial is testing

UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Active Not RecruitingNCT07386938
What this trial is testing

The Efficacy, Safety and Pharmacokinetics of RPH-051 and Perjeta® in Combination With Trastuzumab and Docetaxel as the 1st Line Therapy in Patients With HER2-positive Breast Cancer

Who this might be right for
Locally Advanced Breast CancerMetastatic Breast Cancer
R-Pharm 246
Early research (Phase 1)Looking for participantsNCT07231458
What this trial is testing

Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies

Who this might be right for
Advanced Solid Tumors
Abalos Therapeutics GmbH 27
Early research (Phase 1)Ended earlyNCT01822756
What this trial is testing

An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsPancreatic Cancer
Incyte Corporation 42
Testing effectiveness (Phase 2)Looking for participantsNCT06452602
What this trial is testing

Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 60
Not applicableUnknownNCT05349045
What this trial is testing

Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
The First Affiliated Hospital of Zhengzhou University 300
Early research (Phase 1)Ended earlyNCT02711345
What this trial is testing

A Phase I Clinical Study With Investigational Compound LTT462 in Adult Patients With Specific Advanced Cancers.

Who this might be right for
Ovarian NeoplasmsNon-Small-Cell Lung CarcinomaMelanoma+1 more
Novartis Pharmaceuticals 65
Next Page